ST百灵

002424 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

6.7B ($974.3M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

3.8B

Net Income

36.8M

Gross Margin

N/A

Op. Margin

0.1%

Net Margin

1.0%

ROE

1.1%

ROA

0.5%

D/E

1.23

Dividend Yield

N/A

EPS

0.02

Current Ratio

0.96

Price History

Company Info

Industry	C27医药制造业
Market Segment	SME
Currency	CNY
Fiscal Year	2024

Business Overview

Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines and honey. Its products are used for cardiovascular, cough, cold, gynecological, and pediatric areas. The company was incorporated in 1999 and is headquartered in Anshun, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About ST百灵

Ticker	002424
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业